Overview
- Consolidated revenue rose 13% to Rs 6,304 crore, PAT reached Rs 477 crore, and EBITDA increased 15% to Rs 941 crore with margins at 14.93%.
- Hospital revenues grew 9% to Rs 3,169 crore as occupancy eased to 69% from 73% due to fewer seasonal admissions, while CONGO specialties expanded about 14%.
- Apollo HealthCo revenue advanced 17% to Rs 2,661 crore, EBITDA losses narrowed to roughly Rs 40 crore, and management guided to breakeven within the next two quarters.
- The Competition Commission of India cleared elements of the group’s restructuring involving Apollo HealthCo, Keimed and Apollo Healthtech.
- Apollo began the first tranche of its capacity buildout with 1,600 beds over roughly 14–18 months at about Rs 3,500 crore, as healthcare revenue saw a ~1% drag from fewer Bangladesh patients offset by diversification to other markets.